The U.S. Food and Drug Administration has granted 510(k) clearance to NeuroMetrix, Inc.’s UNIVERSAL Electrodes. NeuroMetrix can, now, launch the electrodes which are to be used in conjunction with the company’s ADVANCE(TM) NCS/EMG System to perform studies in nerve conduction. The UNIVERSAL Electrodes are for single patient use and are disposable. These electrodes will allow doctors to stimulate and record from any peripheral nerve at both proximal and distal sites.

Cyberkinetics Neurotechnology Systems and NeuroMetrix have come together in a 50:50 joint venture, Peripheral Nerve Injury Repair LLC, for the development and commercial launch of a medical product to treat peripheral nerve injury. The product will be based on Cyberkinetics’ Andara Oscillating Field Stimulator (OFS) neurostimulation technology platform. The companies estimate that up to 100,000 people with laceration, stretch and compression injuries may benefit from nerve fiber growth repair treatment using Andara(TM) OFS(TM) Therapy.